| 前收盘价格 | 19.25 |
| 收盘价格 | 17.08 |
| 成交量 | 1,437,362 |
| 平均成交量 (3个月) | 726,655 |
| 市值 | 982,569,408 |
| 市盈率 (P/E TTM) | 14.42 |
| 预期市盈率 (P/E Forward) | 78.12 |
| 价格/销量 (P/S) | 2.53 |
| 股市价格/股市净资产 (P/B) | 2.41 |
| 52周波幅 | |
| 利润日期 | 29 Apr 2026 |
| 营业毛利率 | 17.92% |
| 营业利益率 (TTM) | -9.46% |
| 稀释每股收益 (EPS TTM) | 1.12 |
| 季度收入增长率 (YOY) | 17.50% |
| 总债务/股东权益 (D/E MRQ) | 7.98% |
| 流动比率 (MRQ) | 4.11 |
| 营业现金流 (OCF TTM) | 26.78 M |
| 杠杆自由现金流 (LFCF TTM) | 29.89 M |
| 资产报酬率 (ROA TTM) | -5.20% |
| 股东权益报酬率 (ROE TTM) | 19.54% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看涨 | 看涨 |
| Diagnostics & Research (全球的) | 看涨 | 看涨 | |
| 股票 | CareDx, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.75 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 3.22% |
| 机构持股比例 | 99.39% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Deerfield Management Company, L.P. | 31 Dec 2025 | 2,191,000 |
| Gagnon Securities Llc | 31 Dec 2025 | 1,774,890 |
| Braidwell Lp | 31 Dec 2025 | 1,585,220 |
| Sumitomo Mitsui Trust Group, Inc. | 31 Dec 2025 | 1,446,616 |
| Amova Asset Management Americas, Inc. | 31 Dec 2025 | 1,446,616 |
| Chevy Chase Trust Holdings, Llc | 31 Dec 2025 | 1,081,342 |
| 52周波幅 | ||
| 中 | 21.00 (13.76%) | |
| 总计 | 1 保留 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 25 Feb 2026 | 21.00 (13.76%) | 保留 | 18.46 |
| 15 Dec 2025 | 18.00 (-2.49%) | 保留 | 19.91 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合